The global mergers and acquisitions (M&A) market for labs is off to a strong start in 2008. "Over the past few years, we’ve typically seen four to seven M&A transactions during the first quarter, and the first quarter of 2008 has had seven—four clinical chemistry and three esoteric testing focused transactions valued at nearly $38 million," said Michael Guerrero of Crosstree Capital Partners Inc. (Tampa, Fla.). "The amount of activity seems to be on track for another 30 to 40 transactions for the year despite the current economic climate."

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

May 2008 - Table of Contents

LIR May 2008 (full PDF issue)

Injunction in Hand, Industry Focuses on Repealing Competitive Bidding Demo

Medicare Part B Lab Spending Inches Up 1.6% to $6.8B

Future of Carilion Labs in Question

AmeriPath Helps Boost Quest’s Q1 Revenues Up 16.9% to $1.8B Over Prior Year

Global Lab M&A Market Totaled $38M in Q1 2008

Lab Industry Celebrates Temporary Injunction as Fight Continues to Repeal Competitive Bidding Demo

Denver’s National Jewish Medical Opens $1 Million+ Molecular Dx Lab

Pathologists Fight United Healthcare for Nonpayment in Class Action Suit

Third Wave Teams With DCL Medical Labs for Molecular Dx Partnership

Lab Stocks Post Slight Rebound in April; Index Up 1% Over 5 Weeks

Hawaii Enlists Regional Labs to Expand Flu Testing